Complexation of amyloid fibrils with charged conjugated polymers

Langmuir

Volumn 30, Issue 13, 2014, Pages 3775-3786

  Ghosh, Dhiman ^a   Dutta, Paulami ^a   Chakraborty, Chanchal ^b   Singh, Pradeep K ^a   Anoop, A ^a   Jha, Narendra Nath ^a   Jacob, Reeba S ^a   Mondal, Mrityunjoy ^a   Mankar, Shruti ^a   Das, Subhadeep ^a   Malik, Sudip ^b   Maji, Samir K ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

^b DEPARTMENT OF MATERIALS SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AGGREGATES; ATOMIC FORCE MICROSCOPY; DYES; FUNCTIONAL POLYMERS; GLYCOPROTEINS;

AMYLOID FIBRIL; ASSEMBLY KINETICS; BIOPHYSICAL TECHNIQUES; CHARGED POLYMERS; FIBRILIZATION; IMAGING AGENT; NEUROLOGICAL DISORDERS; PARKINSON'S DISEASE;

CONJUGATED POLYMERS;

ALPHA SYNUCLEIN; AMYLOID; FLUOROCARBON; PROTEIN AGGREGATE; RECOMBINANT PROTEIN; SOLUTION AND SOLUBILITY; THIAZOLE DERIVATIVE; THIOFLAVINE;

AMINO ACID SEQUENCE; ATOMIC FORCE MICROSCOPY; CHEMISTRY; ESCHERICHIA COLI; GENE EXPRESSION; GENETICS; HUMAN; INFRARED SPECTROSCOPY; KINETICS; METABOLISM; MOLECULAR GENETICS; SOLUTION AND SOLUBILITY; STATIC ELECTRICITY; SYNTHESIS;

ALPHA-SYNUCLEIN; AMINO ACID SEQUENCE; AMYLOID; ESCHERICHIA COLI; FLUOROCARBON POLYMERS; GENE EXPRESSION; HUMANS; KINETICS; MICROSCOPY, ATOMIC FORCE; MOLECULAR SEQUENCE DATA; PROTEIN AGGREGATES; RECOMBINANT PROTEINS; SOLUTIONS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STATIC ELECTRICITY; THIAZOLES;

EID: 84897985686     PISSN: 07437463     EISSN: 15205827     Source Type: Journal    
DOI: 10.1021/la404739f     Document Type: Article

References (60)

1. Chiti, F.; Dobson, C. M. Protein misfolding, functional amyloid, and human disease Annu. Rev. Biochem. 2006, 75, 333-366
2. Maji, S. K.; Wang, L.; Greenwald, J.; Riek, R. Structure-activity relationship of amyloid fibrils FEBS Lett. 2009, 583, 2610-2617
3. Jarrett, J. T.; Lansbury, P. T., Jr Seeding "one-dimensional crystallization" of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 1993, 73, 1055-1058
4. Harper, J. D.; Lansbury, P. T., Jr. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins Annu. Rev. Biochem. 1997, 66, 385-407
5. Uversky, V. N.; Fink, A. L. Conformational constraints for amyloid fibrillation: the importance of being unfolded Biochim. Biophys. Acta 2004, 1698, 131-153
6. Uversky, V. N.; Lee, H. J.; Li, J.; Fink, A. L.; Lee, S. J. Stabilization of partially folded conformation during α-synuclein oligomerization in both purified and cytosolic preparations J. Biol. Chem. 2001, 276, 43495-43498
7. Dobson, C. M. The structural basis of protein folding and its links with human disease Philos. Trans. R. Soc. London, B: Biol. Sci. 2001, 356, 133-145
8. Guijarro, J. I.; Sunde, M.; Jones, J. A.; Campbell, I. D.; Dobson, C. M. Amyloid fibril formation by an SH3 domain Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 4224-4228
9. Chiti, F.; Webster, P.; Taddei, N.; Clark, A.; Stefani, M.; Ramponi, G.; Dobson, C. M. Designing conditions for in vitro formation of amyloid protofilaments and fibrils Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 3590-3594
10. Sunde, M.; Blake, C. The structure of amyloid fibrils by electron microscopy and X-ray diffraction Adv. Protein Chem. 1997, 50, 123-159
11. LeVine, H., 3rd. Quantification of β-sheet amyloid fibril structures with thioflavin T Methods Enzymol. 1999, 309, 274-284
12. Klunk, W. E.; Jacob, R. F.; Mason, R. P. Quantifying amyloid by Congo red spectral shift assay Methods Enzymol. 1999, 309, 285-305
13. Klein, W. L.; Stine, W. B., Jr.; Teplow, D. B. Small assemblies of unmodified amyloid β-protein are the proximate neurotoxin in Alzheimer's disease Neurobiol. Aging 2004, 25, 569-580
14. Lashuel, H. A.; Lansbury, P. T., Jr. Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins? Q. Rev. Biophys. 2006, 39, 167-201
15. Winner, B.; Jappelli, R.; Maji, S. K.; Desplats, P. A.; Boyer, L.; Aigner, S.; Hetzer, C.; Loher, T.; Vilar, M.; Campioni, S.; Tzitzilonis, C.; Soragni, A.; Jessberger, S.; Mira, H.; Consiglio, A.; Pham, E.; Masliah, E.; Gage, F. H.; Riek, R. In vivo demonstration that α-synuclein oligomers are toxic Proc. Natl. Acad. Sci. U.S.A. 2011, 108, 4194-4199
16. Cookson, M. R. The biochemistry of Parkinson's disease Annu. Rev. Biochem. 2005, 74, 29-52
17. Lansbury, P. T.; Brice, A. Genetics of Parkinson's disease and biochemical studies of implicated gene products-Commentary Curr. Opin. Cell Biol. 2002, 14, 653-660
18. Feany, M. B. Studying human neurodegenerative diseases in flies and worms J. Neuropath. Exp. Neurol. 2000, 59, 847-856
19. Jakes, R.; Spillantini, M. G.; Goedert, M. Identification of two distinct synucleins from human brain FEBS Lett. 1994, 345, 27-32
20. Bendor, J. T.; Logan, T. P.; Edwards, R. H. The function of α-synuclein Neuron 2013, 79, 1044-1066
21. Lashuel, H. A.; Overk, C. R.; Oueslati, A.; Masliah, E. The many faces of α-synuclein: from structure and toxicity to therapeutic target Nat. Rev. Neurosci. 2013, 14, 38-48
22. Uversky, V. N. Neuropathology, biochemistry, and biophysics of α-synuclein aggregation J. Neurochem. 2007, 103, 17-37
23. Conway, K. A.; Lee, S. J.; Rochet, J. C.; Ding, T. T.; Williamson, R. E.; Lansbury, P. T. Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 571-576
24. Davidson, W. S.; Jonas, A.; Clayton, D. F.; George, J. M. Stabilization of α-synuclein secondary structure upon binding to synthetic membranes J. Biol. Chem. 1998, 273, 9443-9449
25. Jao, C. C.; Der-Sarkissian, A.; Chen, J.; Langen, R. Structure of membrane-bound α-synuclein studied by site-directed spin labeling Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 8331-8336
26. Vilar, M.; Chou, H. T.; Luhrs, T.; Maji, S. K.; Riek-Loher, D.; Verel, R.; Manning, G.; Stahlberg, H.; Riek, R. The fold of α-synuclein fibrils Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 8637-8642
27. Heise, H. H. W.; Becker, S.; Andronesi, O. C.; Riedel, D.; Baldus, M. Molecular-level secondary structure, polymorphism, and dynamics of full-length α-synuclein fibrils studied by solid-state NMR Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 15871-15876
28. Murray, I. V. J.; Giasson, B. I.; Quinn, S. M.; Koppaka, V.; Axelsen, P. H.; Ischiropoulos, H.; Trojanowski, J. Q.; Lee, V. M. Y. Role of α-synuclein carboxy-terminus on fibril formation in vitro Biochemistry 2003, 42, 8530-8540
29. Cohlberg, J. A.; Li, J.; Uversky, V. N.; Fink, A. L. Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from α-synuclein in vitro Biochemistry 2002, 41, 1502-1511
30. Valle-Delgado, J. J.; Alfonso-Prieto, M.; de Groot, N. S.; Ventura, S.; Samitier, J.; Rovira, C.; Fernandez-Busquets, X. Modulation of Aβ42 fibrillogenesis by glycosaminoglycan structure. FASEB J. 24, 4250-4261.
31. Jha, N. N.; Anoop, A.; Ranganathan, S.; Mohite, G. M.; Padinhateeri, R.; Maji, S. K. Characterization of Amyloid Formation by Glucagon-Like Peptides: Role of Basic Residues in Heparin-Mediated Aggregation Biochemistry 2013, 52, 8800-8810
32. Suk, J. Y.; Zhang, F.; Balch, W. E.; Linhardt, R. J.; Kelly, J. W. Heparin accelerates gelsolin amyloidogenesis Biochemistry 2006, 45, 2234-2242
33. Nilsson, K. P.; Aslund, A.; Berg, I.; Nystrom, S.; Konradsson, P.; Herland, A.; Inganas, O.; Stabo-Eeg, F.; Lindgren, M.; Westermark, G. T.; Lannfelt, L.; Nilsson, L. N.; Hammarstrom, P. Imaging distinct conformational states of amyloid-β fibrils in Alzheimer's disease using novel luminescent probes ACS Chem. Biol. 2007, 2, 553-560
34. Nilsson, K. P.; Hammarstrom, P.; Ahlgren, F.; Herland, A.; Schnell, E. A.; Lindgren, M.; Westermark, G. T.; Inganas, O. Conjugated polyelectrolytes - conformation-sensitive optical probes for staining and characterization of amyloid deposits ChemBioChem 2006, 7, 1096-1104
35. Nilsson, K. P.; Lindgren, M.; Hammarstrom, P. A pentameric luminescent-conjugated oligothiophene for optical imaging of in vitro-formed amyloid fibrils and protein aggregates in tissue sections Methods Mol. Biol. 2012, 849, 425-434
36. Sigurdson, C. J.; Nilsson, K. P.; Hornemann, S.; Manco, G.; Polymenidou, M.; Schwarz, P.; Leclerc, M.; Hammarstrom, P.; Wuthrich, K.; Aguzzi, A. Prion strain discrimination using luminescent conjugated polymers Nat. Methods 2007, 4, 1023-1030
37. Margalith, I.; Suter, C.; Ballmer, B.; Schwarz, P.; Tiberi, C.; Sonati, T.; Falsig, J.; Nystrom, S.; Hammarstrom, P.; Aslund, A.; Nilsson, K. P.; Yam, A.; Whitters, E.; Hornemann, S.; Aguzzi, A. Polythiophenes inhibit prion propagation by stabilizing prion protein (PrP) aggregates J. Biol. Chem. 2012, 287, 18872-18887
38. Nilsson, K. P.; Rydberg, J.; Baltzer, L.; Inganas, O. Self-assembly of synthetic peptides control conformation and optical properties of a zwitterionic polythiophene derivative Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 10170-10174
39. Herland, A.; Bjork, P.; Nilsson, K. P.; Olsson, J. D.; Asberg, P.; Konradsson, P.; Hammarstrom, P.; Inganas, O. Electroactive Luminescent Self-assembled Bio-Organic Nanowires:Integration of Semiconducting Oligoelectrolytes within Amyloidogenic Proteins Adv. Mater. 2005, 17, 1466-1471
40. Chakraborty, C.; Singh, P.; Maji, S. K.; Malik, S. Conjugated Polyfluorene-based Reversible Fluorescent Sensor for Cu(II) and Cyanide Ions in Aqueous Medium Chem. Lett. 2013, 42, 1355-1357
41. Thomas, S. W., III; Joly, G. D.; Swager, T. M. Chemical sensors based on amplifying fluorescent conjugated polymers Chem. Rev. 2007, 107, 1339-1386
42. Chakraborty, C.; Dana, K.; Malik, S. Immobilization of poly(fluorene) within clay nanocomposite: an easy way to control keto defect J. Colloid Interface Sci. 2012, 368, 172-180
43. Volles, M. J.; Lansbury, P. T., Jr. Relationships between the Sequence of α-Synuclein and its Membrane Affinity, Fibrillization Propensity, and Yeast Toxicity J. Mol. Biol. 2007, 366, 1510-1522
44. Ghosh, D.; Mondal, M.; Mohite, G. M.; Singh, P. K.; Ranjan, P.; Anoop, A.; Ghosh, S.; Jha, N. N.; Kumar, A.; Maji, S. K. The Parkinson's Disease-Associated H50Q Mutation Accelerates α-Synuclein Aggregation in Vitro Biochemistry 2013, 52, 6925-6927
45. Singh, P. K.; Kotia, V.; Ghosh, D.; Mohite, G. M.; Kumar, A.; Maji, S. K. Curcumin Modulates α-Synuclein Aggregation and Toxicity ACS Chem. Neurosci. 2013, 4, 393-407
46. Recchia, A.; Debetto, P.; Negro, A.; Guidolin, D.; Skaper, S. D.; Giusti, P. α-synuclein and Parkinson's disease FASEB J. 2004, 18, 617-626
47. Walsh, D. M.; Hartley, D. M.; Kusumoto, Y.; Fezoui, Y.; Condron, M. M.; Lomakin, A.; Benedek, G. B.; Selkoe, D. J.; Teplow, D. B. Amyloid β-protein fibrillogenesis-Structure and biological activity of protofibrillar intermediates J. Biol. Chem. 1999, 274, 25945-25952
48. Lashuel, H. A.; Hartley, D. M.; Petre, B. M.; Wall, J. S.; Simon, M. N.; Walz, T.; Lansbury, P. T. Mixtures of wild-type and a pathogenic (E22G) form of Aβ40 in vitro accumulate protofibrils, including amyloid pores J. Mol. Biol. 2003, 332, 795-808
49. Whitmore, L.; Wallace, B. A. Protein secondary structure analyses from circular dichroism spectroscopy: methods and reference databases Biopolymers 2008, 89, 392-400
50. Willander, H.; Presto, J.; Askarieh, G.; Biverstal, H.; Frohm, B.; Knight, S. D.; Johansson, J.; Linse, S. BRICHOS domains efficiently delay fibrillation of amyloid β-peptide J. Biol. Chem. 2012, 287, 31608-31617
51. Morris, A. M.; Watzky, M. A.; Agar, J. N.; Finke, R. G. Fitting neurological protein aggregation kinetic data via a 2-step, minimal/ "Ockham's razor" model: the Finke-Watzky mechanism of nucleation followed by autocatalytic surface growth Biochemistry 2008, 47, 2413-2427
52. Barth, A. Infrared spectroscopy of proteins Biochim. Biophys. Acta 2007, 1767, 1073-1101
53. Hiramatsu, H.; Kitagawa, T. FT-IR approaches on amyloid fibril structure Biochim. Biophys. Acta 2005, 1753, 100-107
54. Singh, P. K.; Maji, S. K. Amyloid-like fibril formation by tachykinin neuropeptides and its relevance to amyloid β-protein aggregation and toxicity Cell Biochem. Biophys. 2012, 64, 29-44
55. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 1983, 65, 55-63
56. Fernandez, C. O.; Hoyer, W.; Zweckstetter, M.; Jares-Erijman, E. A.; Subramaniam, V.; Griesinger, C.; Jovin, T. M. NMR of α-synuclein-polyamine complexes elucidates the mechanism and kinetics of induced aggregation EMBO J. 2004, 23, 2039-2046
57. Hebia, C.; Bekale, L.; Chanphai, P.; Agbebavi, J.; Tajmir-Riahi, H. A. Trypsin inhibitor complexes with human and bovine serum albumins: TEM and spectroscopic analysis J. Photochem. Photobiol. B 2013, 130C, 254-259
58. Burrows, H. D.; Tapia, M. J.; Silva, C. L.; Pais, A. A.; Fonseca, S. M.; Pina, J.; de Melo, J. S.; Wang, Y.; Marques, E. F.; Knaapila, M.; Monkman, A. P.; Garamus, V. M.; Pradhan, S.; Scherf, U. Interplay of electrostatic and hydrophobic effects with binding of cationic gemini surfactants and a conjugated polyanion: experimental and molecular modeling studies J. Phys. Chem. B 2007, 111, 4401-4410
59. Kim, W.; Hecht, M. H. Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer's Aβ42 peptide Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 15824-15829
60. van Rooijen, B. D.; van Leijenhorst-Groener, K. A.; Claessens, M. M.; Subramaniam, V. Tryptophan fluorescence reveals structural features of α-synuclein oligomers J. Mol. Biol. 2009, 394, 826-833